Cost-effectiveness of the withdrawal of treatment with inhaled colistin in patients with adult bronchiectasis not due to cystic fibrosis colonized by Pseudomonas aeruginosa

2020 ◽  
Vol 154 (7) ◽  
pp. 279-280
Author(s):  
Rubén Lera Álvarez ◽  
Eva Martínez Moragón ◽  
María Morales Suárez Varela
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Cost Effectiveness ◽  
Withdrawal Of Treatment

scholarly journals The Cost-Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas Aeruginosa in Patients with Cystic Fibrosis

2013 ◽  
Vol 16 (7) ◽  
pp. A372 ◽  
Author(s):  
P. Tappenden ◽  
S. Harnan ◽  
L. Uttley ◽  
M. Mildred ◽  
C.J. Taylor ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Cost Effectiveness ◽  
Dry Powder ◽  
The Cost

The Cost Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas aeruginosa in Patients with Cystic Fibrosis

2013 ◽  
Vol 32 (2) ◽  
pp. 159-172 ◽  
Author(s):  
Paul Tappenden ◽  
Sue Harnan ◽  
Lesley Uttley ◽  
Matthew Mildred ◽  
Martin Walshaw ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Cost Effectiveness ◽  
Dry Powder ◽  
The Cost

Anti-Pseudomonas aeruginosa IgG Antibodies and Chronic Airway Infection in Non-Cystic Fibrosis Bronchiectasis

Pneumologie ◽  
2016 ◽  
Vol 70 (10) ◽  
Author(s):  
G Suarez-Cuartin ◽  
O Sibila ◽  
A Smith ◽  
H Abo-Leyah ◽  
A Rodrigo-Troyano ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Pseudomonas Aeruginosa ◽  
Igg Antibodies ◽  
Airway Infection ◽  
Chronic Airway
Sign in / Sign up

Export Citation Format

Share Document